Trials / Completed
CompletedNCT00160680
ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)
A Pilot, Open, Monocenter, Randomized Two Parallel Groups, Clinical Efficacy Trial: Comparison Continuous Versus on Demand Regimen of Treatment With Levocetirizine 5 mg Oral Tablets, Once a Day, in Adults Suffering From Persistent Allergic Rhinitis (PER) Over 6 Months
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 62 (actual)
- Sponsor
- UCB S.A. - Pharma Sector · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of clinical efficacy and safety of levocetirizine in PER continuous versus on demand, measured by evolution of individual symptom scores during 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levocetirizine | * Pharmaceutical form: Tablet * Concentration: 5 mg * Route of administration: Oral use |
Timeline
- Start date
- 2005-03-01
- Primary completion
- 2006-06-01
- Completion
- 2006-06-01
- First posted
- 2005-09-12
- Last updated
- 2023-08-31
- Results posted
- 2019-01-22
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00160680. Inclusion in this directory is not an endorsement.